國家衛生研究院 NHRI:Item 3990099045/7969
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 909605      在线人数 : 825
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/7969


    题名: Prognostic factors of radiofrequency ablation for hepatocellular carcinoma: A nationwide cohort study
    作者: Lee, TY;Ho, HJ;Kuo, KN;Lin, JT;Lane, HY;Wu, MS;Wu, CY
    贡献者: Division of Health Services and Preventive Medicine
    摘要: Prognostic factors such as large tumor size and viral factors have not been fully evaluated in hepatocellular carcinoma (HCC) following radiofrequency ablation (RFA). We aimed to investigate prognostic factors of RFA by a nationwide cohort study. Based on Taiwan National Health Insurance Research Database, 50,791 patients with newly diagnosed HCC were screened between July 2004 and December 2011. After excluding combination therapy, vascular invasion, extrahepatic metastasis or follow-up period less than 6 months, 2,261 patients who received RFA as curative therapy were identified. Cumulative incidences of and hazard ratios (HRs) for HCC recurrence and patient mortality were analyzed. With a median follow-up of 33.6 months, 5-year HCC recurrence and overall survival rates were 64.0% (95% confidence interval (CI): 61.5–6.5%) and 52.6% (95% CI: 49.7–55.5%), respec-tively. On multivariate analysis, tumor size >5 cm (HR 1.73; 95% CI, 1.35-2.23), hepatitis B virus infection (HR 1.34; 95% CI, 1.17-1.54), hepatitis C virus infection (HR 1.46; 95% CI, 1.26-1.68) and cirrhosis (HR 1.24; 95% CI, 1.09-1.42) were associated with an increased risk of HCC recurrence, and NSAIDs or aspirin use (HR 0.86; 95% CI, 0.76-0.97) were associated with a decreased risk. In addition, increased age (HR 1.02; 95% CI, 1.01-1.03), tumor size >5 cm (HR 1.61; 95% CI, 1.21-2.16), alcoholic liver disease (HR 1.38; 95% CI, 1.01-1.88), cirrhosis (HR 1.50; 95% CI, 1.26-1.79), liver decompensation (HR 1.84; CI, 1.49-2.27) and diabetes (HR 1.50; CI, 1.23-1.83) were associated with an increased risk of patient mortality. Conclusion: HCC patients with prognostic factors such as tumor size >5 cm should be carefully selected for RFA. Chronic viral infection was associated with tumor recurrence after RFA, and antiviral treatment could be further studied.
    日期: 2013-10
    關聯: Hepatology. 2013 Oct;58:1245A.
    Link to: http://dx.doi.org/10.1002/hep.26726
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0270-9139&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000330252206095
    显示于类别:[郭耿南(2003-2010)] 會議論文/會議摘要

    文件中的档案:

    档案 描述 大小格式浏览次数
    ISI000330252206095.pdf103KbAdobe PDF666检视/开启


    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈